Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
J

JNJ

NYSE

JOHNSON & JOHNSON

Latest disclosureSeptember 10, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 11 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 47

Limited filing history
All47Buying0Selling11Other36
Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

47 trades · April 23, 2026 – September 8, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 20 trades on this page.

Award disclosed

Daniel E. Pinto

Director

Deferred Share Units

Derivative security · not the ordinary share price.

Value context
$31.25K
Reported price
$276.31 / derivative unit
Traded September 8, 2026Filed September 10, 2026SEC filing
Award disclosed

Eugene A. Woods

Director

Deferred Share Units

Derivative security · not the ordinary share price.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source
SEC EDGAR · Form 4
Issuer CIK
0000200406
Latest public acceptance
Sep 11, 2026, 12:51 AM UTC
Score calculated
Oct 7, 2026, 12:04 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Value context
$37.5K
Reported price
$276.31 / derivative unit
Traded September 8, 2026Filed September 10, 2026SEC filing
Award disclosed

Marillyn A. Hewson

Director

Deferred Share Units

Derivative security · not the ordinary share price.

Value context
$50K
Reported price
$276.31 / derivative unit
Traded September 8, 2026Filed September 10, 2026SEC filing
Exercise or conversion

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Value context
$1.46M
Reported price
$131.94 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Sale disclosed

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Reported value
$3.04M
Reported price
$274.74 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Exercise or conversion

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Value context
$3.41M
Reported price
$151.41 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Sale disclosed

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Reported value
$6.19M
Reported price
$274.74 / share
Traded September 2, 2026Filed September 4, 2026SEC filing
Exercise or conversion

Timothy Schmid

EVP, WW Chair, MedTech

Employee Stock Options (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$131.94 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 2, 2026Filed September 4, 2026SEC filing
Exercise or conversion

Timothy Schmid

EVP, WW Chair, MedTech

Employee Stock Options (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$151.41 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 2, 2026Filed September 4, 2026SEC filing
Exercise or conversion

Jennifer L. Taubert

EVP, WWC. Innovative Medicine

Common Stock

Value context
$1.74M
Reported price
$115.67 / share
Traded August 17, 2026Filed August 18, 2026SEC filing
Sale disclosed

Jennifer L. Taubert

EVP, WWC. Innovative Medicine

Common Stock

Reported value
$3.95M
Reported price
$263.36 / share
Traded August 17, 2026Filed August 18, 2026SEC filing
Exercise or conversion

Jennifer L. Taubert

EVP, WWC. Innovative Medicine

Employee Stock Options (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$115.67 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 17, 2026Filed August 18, 2026SEC filing
Exercise or conversion

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Value context
$14.26M
Reported price
$115.67 / share
Traded August 13, 2026Filed August 14, 2026SEC filing
Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value
$5.5M
Reported price
$262.00 / share
Traded August 13, 2026Filed August 14, 2026SEC filing
Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value
$26.7M
Reported price
$261.00 / share
Traded August 13, 2026Filed August 14, 2026SEC filing
Exercise or conversion

Joaquin Duato

CEO and Chairman of the Board

Employee Stock Options (Right to Buy)

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
$115.67 exercise / conversion price
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded August 13, 2026Filed August 14, 2026SEC filing
Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value
$10.83M
Reported price
$258.056 / share
Traded August 5, 2026Filed August 7, 2026SEC filing
Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value
$1.69M
Reported price
$258.739 / share
Traded August 5, 2026Filed August 7, 2026SEC filing
Exercise or conversion

Elizabeth Forminard

EVP, Chief Legal Officer

Common Stock

Value context
$1.23M
Reported price
$131.94 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Sale disclosed

Elizabeth Forminard

EVP, Chief Legal Officer

Common Stock

Reported value
$2.41M
Reported price
$257.755 / share
Traded August 6, 2026Filed August 7, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorDeferred Share UnitsGrant or awardDerivative units113$276.31 / derivative unit$31.25KSep 8Filed Sep 10 · 2d laterSEC filing
DirectorDeferred Share UnitsGrant or awardDerivative units136$276.31 / derivative unit$37.5KSep 8Filed Sep 10 · 2d laterSEC filing
DirectorDeferred Share UnitsGrant or awardDerivative units181$276.31 / derivative unit$50KSep 8Filed Sep 10 · 2d laterSEC filing
EVP, WW Chair, MedTechCommon StockOption exercise or conversion11,070$131.94 / share$1.46MSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WW Chair, MedTechCommon StockSale11,070$274.74 / share$3.04MSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WW Chair, MedTechCommon StockOption exercise or conversion22,527$151.41 / share$3.41MSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WW Chair, MedTechCommon StockSale22,527$274.74 / share$6.19MSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WW Chair, MedTechEmployee Stock Options (Right to Buy)Option exercise or conversionDerivative units11,070$131.94 exercise / conversion priceNot a separate purchaseSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WW Chair, MedTechEmployee Stock Options (Right to Buy)Option exercise or conversionDerivative units22,527$151.41 exercise / conversion priceNot a separate purchaseSep 2Filed Sep 4 · 2d laterSEC filing
EVP, WWC. Innovative MedicineCommon StockOption exercise or conversion15,000$115.67 / share$1.74MAug 17Filed Aug 18 · 1d laterSEC filing
EVP, WWC. Innovative MedicineCommon StockSale15,000$263.36 / share$3.95MAug 17Filed Aug 18 · 1d laterSEC filing
EVP, WWC. Innovative MedicineEmployee Stock Options (Right to Buy)Option exercise or conversionDerivative units15,000$115.67 exercise / conversion priceNot a separate purchaseAug 17Filed Aug 18 · 1d laterSEC filing
CEO and Chairman of the BoardCommon StockOption exercise or conversion123,291$115.67 / share$14.26MAug 13Filed Aug 14 · 1d laterSEC filing
CEO and Chairman of the BoardCommon StockSale2 trades123,291avg $261.17 / share$32.2MAug 13Filed Aug 14 · 1d later
2 filings
  • 20,976 @ $262.00 · $5.5MSEC filing
  • 102,315 @ $261.00 · $26.7MSEC filing
CEO and Chairman of the BoardEmployee Stock Options (Right to Buy)Option exercise or conversionDerivative units123,291$115.67 exercise / conversion priceNot a separate purchaseAug 13Filed Aug 14 · 1d laterSEC filing
CEO and Chairman of the BoardCommon StockSale2 trades48,480avg $258.15 / share$12.52MAug 5Filed Aug 7 · 2d later
2 filings
  • 41,957 @ $258.06 · $10.83MSEC filing
  • 6,523 @ $258.74 · $1.69MSEC filing
EVP, Chief Legal OfficerCommon StockOption exercise or conversion9,344$131.94 / share$1.23MAug 6Filed Aug 7 · 1d laterSEC filing
EVP, Chief Legal OfficerCommon StockSale9,344$257.76 / share$2.41MAug 6Filed Aug 7 · 1d laterSEC filing

Showing the latest 20 of 47 trades. Show all 47 trades

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Congress transactions 29

All Congress filings
Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd Doggett official portraitLloyd DoggettReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
September 8, 2026
Filed October 5, 2026 · 27d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 27, 2026
Filed September 12, 2026 · 16d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a partial sale for a joint account.

John Boozman official portraitJohn BoozmanReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
August 20, 2026
Filed September 11, 2026 · 22d laterOriginal report
Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
July 30, 2026
Filed August 14, 2026 · 15d laterOriginal report
Full sale disclosedAmended report

Johnson & Johnson Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
October 29, 2024
Filed August 5, 2026 · 645d laterOriginal report
Full sale disclosedAmended report

Johnson & Johnson Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H Tuberville official portraitThomas H TubervilleReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
October 29, 2024
Filed August 5, 2026 · 645d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 30, 2026
Filed July 21, 2026 · 113d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
June 29, 2026
Filed July 15, 2026 · 16d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
June 2, 2026
Filed July 15, 2026 · 43d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd Doggett official portraitLloyd DoggettReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
June 9, 2026
Filed July 6, 2026 · 27d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a partial sale for a joint account.

John Boozman official portraitJohn BoozmanReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 19, 2026
Filed April 14, 2026 · 26d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 26, 2026
Filed April 13, 2026 · 18d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 19, 2026
Filed April 7, 2026 · 19d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 19, 2026
Filed April 7, 2026 · 19d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd Doggett official portraitLloyd DoggettReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 10, 2026
Filed April 6, 2026 · 27d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
January 23, 2026
Filed February 19, 2026 · 27d laterOriginal report
Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 18, 2025
Filed January 15, 2026 · 28d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd Doggett official portraitLloyd DoggettReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
December 9, 2025
Filed January 2, 2026 · 24d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
November 20, 2025
Filed December 19, 2025 · 29d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a joint account.

Julie Johnson official portraitJulie JohnsonReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 13, 2025
Filed December 11, 2025 · 28d laterOriginal report
Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormick official portraitRichard Dean Dr McCormickReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
November 5, 2025
Filed December 9, 2025 · 34d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a dependent.

Jared Moskowitz official portraitJared MoskowitzReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 10, 2025
Filed November 22, 2025 · 43d laterOriginal report
Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a dependent.

Jared Moskowitz official portraitJared MoskowitzReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 10, 2025
Filed November 22, 2025 · 43d laterOriginal report
Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for a spouse.

Lisa McClain official portraitLisa McClainReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
October 31, 2025
Filed November 21, 2025 · 21d laterOriginal report

Showing the latest 25 of 29 disclosed trades. Show all 29 trades